ICON Backs Annual Guidance, Initiates 2025 Outlook; Pre-Market Stock Down
ICON Plc (ICLR), healthcare intelligence and clinical research company, on Tuesday reaffirmed its annual guidance. In addition, the ...
Icon backs FY24 adjusted EPS view $13.90-$14.10, consensus $13.97
B, consensus $8.28B. The company said, “With respect to full year 2024, the company reaffirmed its current guidance of revenue in the range of $8,260 – $8,300 million and adjusted earnings per share* ...
ICON Issues Financial Guidance for Full Year 2025
Full year 2025 revenue guidance in the range of $8,050 - $8,650 million; midpoint of $8,350 million representing growth of ...